Executive Leadership

Ron Sparks, Chairman & CEO

Ron Sparks joined Avista Capital Partners in 2007 as a healthcare industry advisor. In this position, he spearheaded the company’s purchase of Boston Scientific’s Fluid Management and Vascular Access businesses. He now serves as CEO and Chairman of this new company, Navilyst Medical.

Ron is a 30-year veteran of the medical technology industry. He served as CEO and President of Accellent, a former portfolio company of DLJ Merchant Banking Partners (DLJMB). Under Ron’s leadership, Accellent’s revenue tripled and all three of its major device categories – cardiology, endoscopy and orthopedics – experienced significant growth. Ron also led Accellent’s acquisition and integration of MedSource Technologies.

He joined Accellent following a 20-year career at Smith & Nephew, where he served as President of the Endoscopy Division and as a member of the Group Executive Committee. Ron is a graduate of the Management Program at the University of Massachusetts and the INSEAD Advanced Management Program in Fontainebleau, France.

Click to view Corporate Video

New Xcela^® Power Injectable Ports
For clinicians who seek power injectability, Navilyst Medical’s new Xcela^® Power Injectable Ports deliver the widest array of port options to satisfy the demands of physician preferences and patient characteristics.

New EZ Huber^® Safety Infusion Set
A unique dual-action safety mechanism reduces exposure to bloodborne pathogens. The safety shield prevents accidental needle sticks followed by a protective cover which surrounds the entire needle after withdrawal to contain aerosolized or splattered infusion fluids and blood. The EZ Huber^® Safety Infusion Set is compatible with any standard or power injectable port, including our new Xcela^® Power Injectable Port and is rated for up to 5mL/sec at 300 psi for contrast-enhanced CT imaging procedures.